| Literature DB >> 31375711 |
David R Olivenza1, Hervé Nicoloff2, María Antonia Sánchez-Romero1, Ignacio Cota1,3, Dan I Andersson2, Josep Casadesús4.
Abstract
We describe a portable epigenetic switch based on opvAB, a Salmonella enterica operon that undergoes bistable expression under DNA methylation control. A DNA fragment containing the opvAB promoter and the opvAB upstream regulatory region confers bistability to heterologous genes, yielding OFF and ON subpopulations. Bistable expression under opvAB control is reproducible in Escherichia coli, showing that the opvAB switch can be functional in a heterologous host. Subpopulations of different sizes can be produced at will using engineered opvAB variants. Controlled formation of antibiotic-resistant and antibiotic-susceptible subpopulations may allow use of the opvAB switch in the study of bacterial heteroresistance to antibiotics.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31375711 PMCID: PMC6677893 DOI: 10.1038/s41598-019-47650-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Formation of LacOFF and LacON subpopulations under opvAB control. (A) Diagram of the opvAB promoter and regulatory region, with the GATC sites outlined. (B) Diagram of the wild type opvAB operon and the P::lacZY construct. (C) Colonies formed on LB + X-gal by a S. enterica strain carrying the lacZY operon under the control of the wild type opvAB control region (SV9700, left), and by S. enterica strains carrying the lacZY operon under the control of mutant opvAB control regions (SV9701, P GATC1,2::lacZY::gfp, center; SV9702, P GATC-less::lacZY::gfp, right). (D) Flow cytometry analysis of P::lacZY expression in strains SV9700, SV9701 and SV9702. The sizes of LacON subpopulations are indicated. (E) Growth of strains SV9700, SV9701 and SV9702 in NCE-lactose. Error bars represent the standard error of the mean from 3 independent replicates. (F) Reversible formation of LacOFF and LacON subpopulations under opvAB control in strain SV9700.
Figure 2Formation of LacOFF and LacON subpopulations under opvAB control in E. coli. (A) Left: Colonies formed on LB + X-gal by an E. coli strain carrying the lacZY operon under the control of the wild type opvAB control region (strain DR22). Center and right: Colonies formed on LB + X-gal by E. coli strains carrying the lacZY operon under the control of mutant opvAB control regions (DR23 and DR24). (B) Flow cytometry analysis of P::lacZY expression in strains DR22, DR23 and DR24. The sizes of LacON subpopulations are indicated. (C) Growth of strains DR22, DR23 and DR24 in NCE-lactose. Error bars represent the standard error of the mean from 3 independent replicates.
Figure 3(A) Growth of strains SV9703 (P::aac6::gfp), SV9705 (P GATC-less::aac6::gfp) SV9706 (P::ctxM::gfp) and SV9707 (P GATC-less::ctxM::gfp) in LB and in LB + antibiotic (kanamycin and cefotaxime, respectively). (B) Left: reversibility of formation of Kms and Kmr subpopulations under opvAB control. Right: reversibility of formation of CtxMs and CtxMr subpopulations under opvAB control.
Figure 4The opvAB switch as a tool for the study of antibiotic heteroresistance. (A) Population analysis profile (PAP) tests of kanamycin resistance in strains SV9776 and SV9777 (carrying P::BI-aac3::gfp and P::gfp constructs, respectively). The proportions indicated are those of the mixtures of SV9776:SV9777. Error bars represent standard deviations of three independent mixtures. (B) Epsilometer tests (Etests) performed on the same mixtures of SV9776 and SV9777. The kanamycin resistant subpopulations appear as low-density lawns (mixtures 1:0 and 1:10) or as isolated colonies growing at kanamycin concentrations above the MIC of the main susceptible population ([Km] > 1 mg/L - mixtures 1:10 to 1:10,000). No kanamycin resistant subpopulation exists for the 0:1 mixture.
Bacterial strains and plasmids.
| Strain | Genotype |
|---|---|
| ATCC 14028a | Wild type |
| MG1655b | Wild type |
| CC118 λ | |
| S17 λ | |
| DA52596a | |
| SV6727a | |
| SV6729a | |
| SV8499a | |
| SV9700a | |
| SV9701a | P |
| SV9702a | P |
| SV9703a | P |
| SV9705a | P |
| SV9706a | P |
| SV9707a | P |
| DR3a | ∆ |
| DR22b | ∆ |
| DR23b | ∆ |
| DR24b | ∆ |
| MN441a | P |
| MN442a | P |
| SV9776a | P |
| SV9777a | P |
| Plasmid | Description |
| pIZ2224 | pDMS197::P |
| pIZ2234 | pDMS197::P |
aS. enterica; bE. coli.
Oligonucleotides.
| Name | Sequence (5′-3′) | Use |
|---|---|---|
| Operonlac-PS1 | ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGTAGGCTGGAGATGCTTC | Amplification of Kmr gene from pKD4 |
| Operonlac-PS2 | TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATCATATGAATAT | |
| MG1655-opvA | ATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATTCATTTGGTTATAAATAGAG | Amplification of the |
| MG1655-opvB | TAGGCCTGATAAGCGCAGCGTATCAGGCAATTTTTATAATGAGTTTATCTCTGCGCAATGT | |
| pCE40lacY-gfp-5 | GCTTTCCCTGCTGCGTCGTCAGGTGAATGAAGTCGCTTAATAAGAAGGAGATATACATATGAG | Amplification of |
| pCE40-km-3 | AAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTTTATCACTTATTACAGGCGTA | |
| opvA-aac6-F | TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGAGCAACGCAAAAACAAAG | Amplification of the |
| aac6-gfp-R | AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTAGGCATGACTGCGTGTTC | |
| opvA-ctxm-F | TCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGGTTAAAAAATCACTGCG | Amplification of the |
| ctxm-gfp-R | AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTATTACAAACCGTCGGTGACGA | |
| PopvAB-aac3-F | ATCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGCATACGCGGAAGGCAATAAC | Amplification of the |
| GFP-aac3-R | GAAAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACTAACCGGAAGGCTCGCAAG | |
| opvAB-ampsacB-F | TCTTATGTGTGGGTTTTATCTTATGAAGAAATATACGTTCGCTAAGGAGGTTTTCTAATGTAGGCTGGAGCTGCTTC | Amplification of the |
| ampsacB-gfp-R | AAAGTTCTTCTCCTTTACTCATATGTATATCTCCTTCTTACATATGAATATCCTCCTTAGTTCC |